Professor of Medicine and Public Health, Director of Health Services Research, Cedars-Sinai Health System; Cedars-Sinai Site Director, Clinical and Translational Science Institute (CTSI); Assistant Dean, David Geffen School of Medicine at UCLA
Cedars-Sinai
Los Angeles, CA
Brennan Spiegel, MD, MSHS, FACG, is director of Health Services Research for Cedars-Sinai and Director of the Cedars-Sinai Master's Degree Program in Health Delivery Science. He directs the Cedars-Sinai Center for Outcomes Research and Education (CS-CORE), a multidisciplinary team that investigates how digital health technologies, including wearable biosensors, smartphone applications, virtual reality (VR) and social media, can strengthen the patient-doctor bond, improve outcomes and save money. His team developed one of largest and most widely-documented medical VR programs at Cedars-Sinai, and his work has helped to support a new field of medicine called Medical Extended Reality, or "MXR."
Spiegel has published numerous best-selling medical textbooks, editorials and more than 250 articles in peer-reviewed journals. He is listed in the Onalytica "Top 100 Influencer" lists for digital health and virtual reality. His digital health research has been featured by major media outlets, including The New York Times, Bloomberg, CBS News, Forbes, Huffington Post, LA Times, NBC News, Reuters, The Washington Post, and the Wall Street Journal. Dr. Spiegel published the book "VRx: How Immersive Therapeutics Will Revolutionize Medicine" (Basic Books, NY, NY), which was named by Wired Magazine as one of its top 8 science books of 2020. Beyond his focus on digital health innovations, Spiegel conducts psychometric, health-economic, epidemiologic and qualitative research across a wide range of healthcare topics. His research team has received funding from the NIH, RWJ Foundation, State of California Precision Medicine Program, PCORI, VA and industry sources. Spiegel is the immediate past editor-in-chief of the American Journal of Gastroenterology. He was among the first group of clinical researchers to examine the gastrointestinal manifestations of COVID-19. He continues to practice clinical medicine and maintains an academic teaching practice at Cedars-Sinai.
Monday, October 24, 2022
ON DEMAND (Must purchase Bonus Sessions to have access)
Monday, October 24, 2022
7:00 AM – 7:45 AM ET